YASUI HIROFUMI | Divison of Gastrointestinal Oncology, Shizuoka Cancer Center

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum
Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel
Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts : role of interleukin-17
Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer : a retrospective review of 65 Japanese patients
Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer : retrospective analysis

スポンサーリンク